Otomycosis: Diagnosis and treatment

Clinics in Dermatology

Volumn 28, Issue 2, 2010, Pages 202-211

  Vennewald, Irina ^a   Klemm,, Eckart ^a  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; ALUMINUM ACETATE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BIFONAZOLE; BORIC ACID; CICLOPIROXOLAMINE; CLOTRIMAZOLE; CRYSTAL VIOLET; ECONAZOLE; FLUCONAZOLE; GRAMICIDIN; HYDROCORTISONE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; MERBROMIN; MICONAZOLE; NAFTIFINE; NATAMYCIN; NEOMYCIN; NYSTATIN; POSACONAZOLE; PYRIDONE DERIVATIVE; TERBINAFINE; THIOCARBAMIC ACID DERIVATIVE; TOLNAFTATE; TRIAMCINOLONE ACETONIDE; TRIAZOLE DERIVATIVE; UNINDEXED DRUG; VORICONAZOLE;

ANAMNESIS; ASPERGILLUS; CANDIDA; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; EARDRUM; EXTERNAL OTITIS; FUNGUS CULTURE; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; MASTOIDITIS; MENINGITIS; MICROSCOPY; MYCOLOGY; MYCOSIS; NONHUMAN; NOTE; OTOMYCOSIS; OTOSCOPY; PATHOGENESIS; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; AMPHOTERICIN B; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; CLOTRIMAZOLE; DRUG RESISTANCE, FUNGAL; ECONAZOLE; HUMANS; ITRACONAZOLE; MICONAZOLE; MYCOSES; OINTMENTS; OTITIS EXTERNA;

EID: 77950259434     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.12.003     Document Type: Note

References (86)

1. Vennewald I., Schönlebe J., Klemm E. Mycological and histological investigations in humans with middle ear infections. Mycoses 2003, 46:12-18.
2. Gutierrez P.H., Alvarez S.J., Sanudo E.G., et al. Presumed diagnosis: a study of 451 patients. Acta Otorrinoloringol Esp 2005, 56:181-186.
3. Fasunla J., Ibekwe T., Onakoya P. Otomycosis in western Nigeria. Mycoses 2008, 51:67-70.
4. Enweani I.B., Iqumbor H. Prevalence of otomycosis in malnourished children in Edo State, Nigeria. Mycopathologia 1997-1998, 140:85-87.
5. Loh K.S., Tan K.K., Kumarasinghe B., Leong H.K., Yeoh K.H. Otitis externa-the clinical pattern in a tertiary institution in Singapore. Ann Acad Med Singapore 1998, 27:215-218.
6. Dorko E., Jenca A., Orencák M., Virágová S., Pilipcinec E. Otomycoses of candidal origin in eastern Slovakia. Folia Microbiol (Praha) 2004, 49:601-604.
7. Amigot S.L., Gomez C.R., Luque A.G., Ebner G. Microbiogical study of external otitis in Rosario City, Argentina. Mycoses 2003, 46:312-315.
8. Bineshian F., Irajian G., Koochak-Alavi S.K., et al. A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol 2006, 1:141-144.
9. Choo M.J., Yang S.K., Jin H.R., Lee O.J. Localized cryptococcal infection combined with cholesteatoma of the ear. Otolaryngol Head Neck Surg 2002, 126:453-454.
10. Bhally H.S., Shields C., Lin S.Y., Merz W.G. Otitis caused by Scedosporium apiospermum in an immunocompetent child. Int J Pediatr Otorhinolaryngol 2004, 68:975-978.
11. Schönborn C., Holzegel K. Zur Pilzflora des gesunden äuβeren Gehörganges. Dermatol Wochenschr 1967, 153:760-770.
12. Watanabe S. Dermatophytosis of the external auditory meatus. J Med Vet Mycol 1986, 24:485-486.
13. Derebery M.J., Berliner K. Foot and ear disease-the dermatophytid reaction in otology. Am Laryngol Rhinol Otol Soc Annu Meet Pap 1995, 106:181-186.
14. Buzina W., Lang-Loidolt D., Ginter-Hanselmayer G. Trichophyton rubrum in the external auditory meatus. Mycoses 2004, 47:85-86.
15. Ozcan M., Ozcan K.M., Karaaslan A., et al. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Arch Otorhinoloringol 2003, 260:24-27.
16. Ohki M., Ito K., Ishimoto S.I. Fungal mastoiditis in an immunocompetent adult. Eur Arch Otorhinolaryngol 2001, 258:106-108.
17. Tiwari S., Singh S.M., Jain S. Chronic bilateral suppurative otitis media caused by Aspergillus terreus. Mycoses 1995, 38:297-300.
18. Cunningham M., Yu V.L., Turner J., Curtin H. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg 1988, 114:554-556.
19. Hoshino T., Matsumoto M. Otomycosis: subdermal growth in calcified mass. Eur Arch Otorhinolaryngol 2006, 263:875-878.
20. Dhindsa M.K., Maidu J., Singh S.M., et al. Chronic suppurative otitis media caused by Paecilomyces variotii. J Med Vet Mycol 1995, 33:59-61.
21. Borkowski G., Gurr A., Stark T., et al. Funktionelle und morphologische Störungen des mukoziliären Systems bei der sekretorischen Otitis media. Laryngorhinootologie 2000, 79:135-138.
22. Agius A.M., Pickles J.M., Burch K.L. A prospective study of otitis externa. Clin Otolaryngol Allied Sci 1992, 17:150-154.
23. Wang M.C., Liu C.Y., Shiao A.S., Wang T. Ear problems in swimmers. J Chin Med Assoc 2005, 68:347-352.
24. Haruna S., Haruna Y., Schachern P.A., et al. Histopathology update: otomycosis. Am J Otolaryngol 1994, 15:74-78.
25. Chen D., Lalwani A.K., House J.W. Choo D. Aspergillus mastoiditis in acquired immunodeficiency syndrome. Am J Otol 1999, 20:561-567.
26. Strauss M., Fine E. Aspergillus otomastoiditis in acquired immunodeficiency syndrome. Am J Otol 1991, 12:49-53.
27. Muñoz A., Martínez-Chamorro E. Necrotizing external otitis caused by Aspergillus fumigatus: computed tomography and high resolution magnetic resonance imaging in an AIDS patient. J Laryngol Otol 1998, 112:98-102.
28. Bellini C., Antonini P., Ermanni S., et al. Malignant otitis externa due to Aspergillus niger. Scand J Infect Dis 2003, 35:284-288.
29. Phillips P., Bryce G., Shepherd J., Mintz D. Invasive external otitis caused by Aspergillus. Rev Infect Dis 1990, 12:277-281.
30. Gordon G., Giddings N.A. Invasive otitis externa due to Aspergillus species: case report and review. Clin Infect Dis 1994, 19:866-870.
31. Menachof M.R., Jackler R.K. Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryngol Head Neck Surg 1990, 102:285-289.
32. Carfrae M.J., Kesser B.W. Malignant otitis externa. Otolaryngol Clin North Am 2008, 41:537-549.
33. Sreepada G.S., Kwartler J.A. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 2003, 11:316-323.
34. Monod M., Baudraz F., Ramelet A.A., et al. Direct mycological examination in dermatology: a comparison of different methods. Dermatologica 1989, 179:183-186.
35. Rüchel R., Schaffrinski M., Seshan K.R., Cole G.T. Vital staining of fungal elements in deep-seated mycotic lesions during experimental murine mycoses using the parenterally applied optical brightener Blankophor. Med Mycol 2000, 38:231-237.
36. Seibold M., Tintelnot K. Susceptibility testing of fungi-current status and open questions. Antifungal agents: advances and problems 2003, 193-241. Basel, Birkhäuser. E. Jucker (Ed.).
37. Karaarslan A., Arikan S., Ozcan M. In vitro-activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis. Mycoses 2004, 47:284-287.
38. Kaya A.D., Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses 2007, 50:447-450.
39. Polak A., Jäckel A., Noack A., Kappe R. Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives. Mycoses 2004, 47:184-192.
40. Munguia R., Daniel S.J. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinoloryngol 2008, 72:453-459.
41. Dyckhoff G., Hoppe-Tichy T., Kappe R., Dietz A. Antimykotische Therapie bei Otomykose mit Trommelfelldefekt. HNO 2000, 48:18-21.
42. Bambule J., Grigoriu D. Otomycoses and their treatment. Mykosen Suppl 1978, 1:82-86.
43. Piantoni S., Narne S., Bottin R., Solazzo A., Bianchi W. Bifonazolo lozione 1% nella terapia delle otomicosi. Clin Ter 1989, 130:23-27.
44. Paulose K., Khalifa F., Shenoy F., et al. Mycotic infection of the ear (otomycosis). A prospective study. J Laryngol Otol 1989, 103:30-35.
45. Del Palacio A., López-Suso M.J., Moore M.K., et al. Long term follow-up of otomycosis and its treatment with bifonazole. J Med Vet Mycol 1993, 31:435-447.
46. Tisner J., Millán J., Rivas P., et al. [Otomycosis and topical application of thimerosal: study on 152 cases]. Acta Otorrinolaringol Esp 1995, 46:85-89.
47. Chander J., Maini S., Subrahmanyan S., et al. Otomycosis-a clinico-mycological study and efficacy of mercurochrome in its treatment. Mycopathologia 1991, 135:9-12.
48. Kurnatowski P., Filipiak A. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses 2001, 44:472-479.
49. Del Palacio A., Cuétara M.S., López-Suso M.J., et al. Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis. Mycoses 2002, 45:317-328.
50. Kunelskaia V.Y. [Fungale otitis: new treatment options]. Vestn Otorinolaringol 2004, 46-48.
51. Kriukov A.I., Shadrin G.B., Balandin A.V., et al. [Lamisil in the treatment of patients with oto- and pharyngomycoses]. Vestn Otorinolaringol 2005, 47-49.
52. Jackman A., Ward R., April M., Bent J. Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol 2005, 69:857-860.
53. Martin T.J., Kerschner J.E., Flanary V.A. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol 2005, 69:1503-1508.
54. Ho T., Vrabec J.T., Yoo D., Coker N.J. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg 2006, 135:787-791.
55. Kiakojuri K., Roushan M., Sepidgar S. Suction clearance and 2% topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian J Trop Med Public Health 2007, 38:749-752.
56. Kunelskaia V.Y., Shadrin G.B. [The efficiency and safety of stepwise exoderil therapy for otitis external mycotica]. Vestn Otorinolaringol 2008, 59-62.
57. Brummett R.E., Harris R.F., Lindgren J.A. Detection of ototoxicity from drugs applied topically to the middle ear space. Laryngoscope 1976, 86:1177-1187.
58. Spandow O., Anniko M., Moller A. The round window as access route for agents injurious to the inner ear. Am J Otolaryngol 1988, 9:327-335.
59. Marsh R.R., Tom L.W.C. Ototoxicity of antimycotics. Otolaryngol Head Neck Surg 1989, 100:134-136.
60. Tom L.W.C. Ototoxicity of common topical antimycotic preparations. Laryngoscope 2000, 110:509-515.
61. Jinn T.H., Kim P.D., Russell P.T., et al. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells. Laryngoscope 2001, 111:2105-2108.
62. Lawrence T.L., Ayers L.W., Sauders W.H. Drug therapy in otomycosis: an in vitro study. Laryngoscope 1978, 88:1755-1760.
63. Stern J.C., Shah M.K., Lucente F.E. In vitro effectiveness of 13 agents in otomycosis and review of the literature. Laryngoscope 1988, 98:1173-1177.
64. Behrens-Baumann W. Antifungal agents. Mycosis of the eye and its adnexa 1999, 27-51. Karger, Basel. W. Behrens-Baumann (Ed.).
65. Jue S.G., Dauson G.W., Brogden R.N. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use. Drugs 1985, 29:330-341.
66. Harley W.B., Dummer J.S., Anderson T.L., Goodman S. Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs. Clin Infect Dis 1995, 20:1052-1054.
67. Hall P.J., Farrior J.B. Aspergillus mastoiditis. Otolaryngol Head Neck Surg 1993, 108:167-170.
68. Tuzcu A., Bahceci M., Celen M.K., et al. Necrotizing (malignant) otitis externa: an unusual localization of mucormycosis. Indian J Med Microbiol 2006, 24:289-291.
69. Goyal A., Tyagi I., Syal R., Marak R.S., Singh J. Apophysomyces elegans causing acute otogenic cervicofacial zygomycosis involving salivary glands. Med Mycol 2007, 45:457-461.
70. Yates P.D., Upile T., Axon P.R., et al. Aspergillus mastoiditis in a patient with acquired immunodeficiency syndrome. J Laryngol Otol 1997, 111:560-561.
71. Kuruvilla G., Job A., Mathew J., Ayyappan A.P., Jacob M. Septate fungal invasion in masked mastoiditis: a diagnostic dilemma. J Laryngol Otol 2006, 120:250-252.
72. Slack C., Watson D.W., Abzug M.J., et al. Fungal mastoiditis in immunocompromised children. Arch Otolaryngol Head Neck Surg 1999, 125:73-75.
73. Finer G., Greenberg D., Leibovitz E., et al. Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient. Scand J Infect Dis 2001, 34:227-229.
74. Kok J., Gilroy N., Halliday C., et al. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae. J Infect 2007, 55:e33-e36.
75. Ferguson T.D., Schniederjan S.D., Dionne-Odom J., et al. Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes. J. Clin Microbiol 2007, 45:1648-1651.
76. Parize P., Chandesris M.O., Lanternier F., et al. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review. Antimicrob Agents Chemother 2009, 53:1048-1053.
77. Ling S.S., Sader C. Fungal malignant otitis externa treated with hyperbaric oxygen. Int J Infect Dis 2008, 12:550-552.
78. Amonoo-Kuofi K., Tostevin P., Knight J.R. Aspergillus mastoiditis in a patient with systemic lupus erythematosus: a case report. Skull Base 2005, 15:109-112.
79. Stratov I., Korman T.M., Johnson P.D. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole on an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 2003, 22:277-283.
80. Baumgarthner B.J., Rakita R.M., Backous D.D. Scedosporium apiospermum otomycosis. Am J Otolaryngol 2007, 28:254-256.
81. Mouas H., Lutsar I., Dupont B., et al. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 2005, 40:1141-1147.
82. Denes E., Boumediene A., Durox H., et al. Voriconazole concentrations in synovial fluid and bone tissues. J Antimicrob Chemother 2007, 59:818-819.
83. Schwartz S., Ruhnke M., Ribaud P., et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005, 106:2641-2645.
84. Böhme A., Ruhnke M., Buchheidt D., et al. Treatment of invasive fungal infections in cancer patients-recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2009, 88:97-110.
85. Pappas P.G., Rex J.H., Sobel J.D., et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161-189.
86. Walsh T.J., Anaissie E.J., Denning D.W., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46:327-360.